[177Lu]Lu-PentixaTher - PentixaPharm
Alternative Names: 177Lu PentixaTher - PentixaPharmLatest Information Update: 08 Jun 2024
At a glance
- Originator PentixaPharm
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Leukaemia
Most Recent Events
- 15 May 2024 Preclinical trials in Leukaemia in Germany (IV)
- 11 Apr 2024 Nantes University Hospital plans a phase I/II trial for Leukaemia (Second-line therapy or greater) in France (IV, Injection) (NCT06356922)